José María
Pego Reigosa
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublications in collaboration with researchers from Hospital Universitari de Bellvitge (33)
2024
-
SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort
Lupus Science and Medicine, Vol. 11, Núm. 1
2023
-
Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER)
Seminars in Arthritis and Rheumatism, Vol. 58
-
Immunoglobulins in systemic sclerosis management. A large multicenter experience
Autoimmunity Reviews, Vol. 22, Núm. 11
-
Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER)
Seminars in Arthritis and Rheumatism, Vol. 61
2022
-
Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure
Seminars in Arthritis and Rheumatism, Vol. 52
-
Myo-Spain: Spanish Registry of Patients with Idiopathic Inflammatory Myopathy. Methodology
Reumatologia Clinica, Vol. 18, Núm. 5, pp. 253-259
-
Prevalence of symptomatic axial osteoarthritis phenotypes in Spain and associated socio-demographic, anthropometric, and lifestyle variables
Rheumatology International, Vol. 42, Núm. 6, pp. 1085-1096
2021
-
Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?
Clinical and Experimental Rheumatology, Vol. 39, Núm. 3, pp. 555-563
-
Prevalence of symptomatic osteoarthritis in Spain: EPISER2016 study
Reumatologia Clinica, Vol. 17, Núm. 8, pp. 461-470
-
Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?
Rheumatology (Oxford, England), Vol. 60, Núm. 11, pp. 5329-5336
2020
-
Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality
Lupus, Vol. 29, Núm. 12, pp. 1556-1565
-
Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER).
Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 4, pp. 657-662
-
Development of an application for mobile phones (App) based on the collaboration between the Spanish Society of Rheumatology and Spanish Society of Family Medicine for the referral of systemic autoimmune diseases from primary care to rheumatology
Reumatologia Clinica, Vol. 16, Núm. 5, pp. 373-377
-
Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry)
Lupus, Vol. 29, Núm. 1, pp. 27-36
-
Fracture risk assessment in the general population in Spain by FRAX® algorithm. EPISER2016 study
Medicina Clinica, Vol. 154, Núm. 5, pp. 163-170
-
Hormonal Dependence and Cancer in Systemic Lupus Erythematosus
Arthritis Care and Research, Vol. 72, Núm. 2, pp. 216-224
-
Hydroxychloroquine is associated with a lower risk of polyautoimmunity: Data from the RELESSER Registry
Rheumatology (United Kingdom), Vol. 59, Núm. 8, pp. 2043-2051
-
Prevalence and factors associated with osteoporosis and fragility fractures in patients with primary Sjögren syndrome
Rheumatology International, Vol. 40, Núm. 8, pp. 1259-1265
2019
-
Prevalence of rheumatic diseases in adult population in Spain (EPISER 2016 study): Aims and methodology
Reumatologia Clinica, Vol. 15, Núm. 2, pp. 90-96
-
Pure Membranous Lupus Nephritis: Description of a Cohort of 150 Patients and Review of the Literature
Reumatologia Clinica, Vol. 15, Núm. 1, pp. 34-42